Spots Global Cancer Trial Database for Gefitinib Usage and Outcomes in Routine Treatment
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Gefitinib Usage and Outcomes in Routine Treatment
Official Title: A Multicentre, Retrospective Chart Review Study to Characterise Gefitinib Usage and Outcomes in Routine Treatment
Study ID: NCT01818947
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to understand real world gefitinib usage patterns, patient characteristics and outcomes and to present these for a Caucasian population
Detailed Description: A multicentre, retrospective chart review study to characterise gefitinib usage and outcomes in routine treatment
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Queen Elizabeth Hospital, Birmingham, , United Kingdom
Velindre Nhs Trust, Cardiff, , United Kingdom
Harrogate District Hospital, Harrogate, , United Kingdom
Leeds Teaching Hospitals, Leeds, , United Kingdom
Liverpool Heart and Chest Hospital, Liverpool, , United Kingdom
Mount Vernon Hospital Nhs Trust, London, , United Kingdom
Royal Marsden Hospital, London, , United Kingdom
University College Hospital, London, , United Kingdom
Christie Hospital Nhs Trust, Manchester, , United Kingdom
Nottingham University Hospitals Nhs Trust, Nottingham, , United Kingdom
Northern General Hospital, Sheffield, , United Kingdom
York District Hospital, York, , United Kingdom
Contact Details
Name: Fiona Blackhall, MBCHB FRCP
Affiliation: The Christie NHS Foundation Trust
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
